Guidance Developed for Addressing Use of Nonstatin Therapies
Expert consensus decision pathway developed for patients currently taking statins and needing additional treatment
Atherosclerosis
Moderate-Intensity Statin Plus Ezetimibe Noninferior to High-Intensity for ASCVD
Investigators sought to determine the most effective statin intensity to add to ezetimibe therapy for patients with atherosclerotic cardiovascular disease.
Higher Meat Intake in Older Adults May Raise Risk for ASCVD
Higher intakes of unprocessed red meat, total meat, and total animal source foods (ASF) are associated with higher atherosclerotic cardiovascular disease (ASCVD) risk, with the associations mediated by trimethylamine N-oxide-related metabolites.
Subclinical Atherosclerosis More Likely Among Young Black Adults
Socioeconomically vulnerable non-Hispanic Black young adults are more likely to have subclinical atherosclerosis than Hispanic young adults.
Symptomatic Peripheral Artery Disease and Worse 3-Year Outcomes Following PCI
Researchers examined outcomes following percutaneous coronary intervention with new-generation stents in patients with peripheral artery disease.
Automated Oscillometric ABI Device and Underdiagnosis of Lower Extremity Atherosclerotic Disease
A study was conducted to determine the measurement abilities of an automated oscillometric ABI measurement device for patients with LE atherosclerotic disease.
Statin Use and Recurrent, Terminal Major Adverse Cardiovascular Events
Researchers sought to examine the effect of statin therapy on recurrent major adverse cardiovascular events.
Genetic Testing and Clinical Data Improve Screening for Familial Hypercholesterolemia
A study was conducted to develop a way to screen patient populations for familial hypercholesterolemia via clinical characteristics and genotype data.
Elevated Arterial Stiffness: A Strong, Independent Predictor of Diabetes
A study was conducted to determine if, compared with hypertension, arterial stiffness is a more accurate predictor of diabetes risk.
One-Year Restenosis Rates After Fluoropolymer-Based Drug-Eluting Stent Implantation for PAD
A study was done to determine the 1-year risk for aneurysmal degeneration and restenosis following implantation of fluoropolymer-based drug-eluting stents.
- Loading...
Loading...
Next post in Vascular Medicine
Loading... 
Loading...